Search Results - "Rogers, Chris A"

Refine Results
  1. 1

    Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial by Chakravarthy, Usha, Prof, Harding, Simon P, Prof, Rogers, Chris A, PhD, Downes, Susan M, MD, Lotery, Andrew J, Prof, Culliford, Lucy A, PhD, Reeves, Barnaby C, Prof

    Published in The Lancet (British edition) (12-10-2013)
    “…Summary Background Bevacizumab has been suggested to have similar effectiveness to ranibizumab for treatment of neovascular age-related macular degeneration…”
    Get full text
    Journal Article
  2. 2

    Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery by MURPHY, Gavin J, REEVES, Barnaby C, ROGERS, Chris A, RIZVI, Syed I. A, CULLIFORD, Lucy, ANGELINI, Gianni D

    Published in Circulation (New York, N.Y.) (27-11-2007)
    “…Red blood cell transfusion can both benefit and harm. To inform decisions about transfusion, we aimed to quantify associations of transfusion with clinical…”
    Get full text
    Journal Article
  3. 3

    Malperfusion rather than merely timing of operative repair determines early and late outcome in type A aortic dissection by Narayan, Pradeep, FRCS[CTh], Rogers, Chris A., PhD, Benedetto, Umberto, MD, Caputo, Massimo, MD, Angelini, Gianni D., FRCS, Bryan, Alan J., FRCS[CTh]

    “…Abstract Background Although generally better outcomes are reported in patients undergoing early repair of type A aortic dissection, patients who survive the…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6

    Emulating the MERINO randomised control trial using data from an observational cohort and trial of rapid diagnostic (BSI-FOO) by Evans, Rebecca N, Harris, Jessica, Rogers, Chris A, MacGowan, Alasdair

    Published in PloS one (20-05-2022)
    “…The aim of this study was to emulate the MERINO trial of piperacillin-tazobactam vs meropenem for the definitive treatment of bloodstream infection (BSI)…”
    Get full text
    Journal Article
  7. 7

    Approaches to multiplicity in publicly funded pragmatic randomised controlled trials: a survey of clinical trials units and a rapid review of published trials by Pike, Katie, Reeves, Barnaby C, Rogers, Chris A

    Published in BMC medical research methodology (06-02-2022)
    “…Opinions and practices vary around the issue of performing multiple statistical tests in randomised controlled trials (RCTs). We carried out a study to collate…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Analytical challenges in estimating the effect of exposures that are bounded by follow-up time: experiences from the Blood Stream Infection-Focus on Outcomes study by Evans, Rebecca, Pike, Katie, MacGowan, Alasdair, Rogers, Chris A

    Published in BMC medical research methodology (30-09-2021)
    “…To illustrate the challenges of estimating the effect of an exposure that is bounded by duration of follow-up on all-cause 28-day mortality, whilst…”
    Get full text
    Journal Article
  10. 10

    The EQ-5D-5L is a valid approach to measure health related quality of life in patients undergoing bariatric surgery by Fermont, Jilles M, Blazeby, Jane M, Rogers, Chris A, Wordsworth, Sarah

    Published in PloS one (18-12-2017)
    “…Bariatric surgery is considered an effective treatment for individuals with severe and complex obesity. Besides reducing weight and improving obesity related…”
    Get full text
    Journal Article
  11. 11

    Integrating expert opinions with clinical trial data to analyse low-powered subgroup analyses: a Bayesian analysis of the VeRDiCT trial by Thirard, Russell, Ascione, Raimondo, Blazeby, Jane M, Rogers, Chris A

    Published in BMC medical research methodology (10-12-2020)
    “…Typically, subgroup analyses in clinical trials are conducted by comparing the intervention effect in each subgroup by means of an interaction test. However,…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20